NST-628
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NST-628, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors [Phase 1]